D-0392-2024 Class II Ongoing

Recalled by Hikma Pharmaceuticals USA Inc. — Cherry Hill, NJ

FDA drug recall D-0392-2024 was initiated by Hikma Pharmaceuticals USA Inc. on March 12, 2024 and is designated Class II. Reason for recall: The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot. The recall status is ongoing. Affected quantity: 22,644 ampuls.

Recall Details

Product Type
Drugs
Report Date
March 27, 2024
Initiation Date
March 12, 2024
Termination Date
N/A
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
22,644 ampuls

Product Description

Infumorph (Preservative-free Morphine Sulfate Sterile Solution), 20 mL ampul, Rx only, Manufactured by Hikma Berkeley Heights, NJ 07922, NDC 0641-6039-01

Reason for Recall

The filter included in the carton has an expiration date that has expired prior to the expiration date of the actual product lot.

Distribution Pattern

Nationwide within the United States

Code Information

Lot #: 052001, 052003, Exp. Date 11/2024; 023012, 023014, Exp. Date 08/2024